| Literature DB >> 25755592 |
Abstract
The pathogenesis of portal cavernoma cholangiopathy (PCC) is important as it can impact the choice of treatment modalities. PCC consists of a reversible component, which resolves by decompression of collaterals as well as a fixed component, which persists despite the decompression of collaterals. The reversible component is due to compression by large collaterals located adjacent to the bile duct as well as possibly intracholedochal varices. The fixed component is likely to be due to ischemia at the time of portal vein thrombosis, local ischemia by compression as well as encasement by a solid tumor-like cavernoma comprising of fibrous hilar mass containing multiple tiny collateral veins rather than markedly enlarged portal collaterals. Although cholangiographic abnormalities in portal hypertension are common, the prevalence of symptomatic PCC is low. This is likely to be related to the cause of portal hypertension, the duration of portal hypertension and possibly the pattern of occlusion of the splenoportal axis. There may possibly be higher prevalence of symptomatic PCC in extension of the thrombosis to the splenomesentric veins.Entities:
Keywords: EHPVO, extrahepatic portal vein occlusion; ERC, endoscopic retrograde cholangiography; HABR, hepatic arterial buffer response; ITBL, ischemic-type biliary lesions; MR, magnetic resonance; PCC, portal cavernoma cholangiopathy; PVT, portal vein thrombosis; extrahepatic portal venous obstruction; obstructive jaundice; portal biliopathy; portal cavernoma
Year: 2014 PMID: 25755592 PMCID: PMC4244823 DOI: 10.1016/j.jceh.2013.05.015
Source DB: PubMed Journal: J Clin Exp Hepatol ISSN: 0973-6883